CalciMedica (CALC)

• Market cap: $66.7M
• 1 day: 6.93%
• 5 days: 7.42%
• 1 month: 47.45%
• 3 months: 62.46%
• 6 months: 172.35%
• Year to date: 40.73%
• 1 year: 64.77%
• 5 years: -98.72%
• 10 years: -98%
• Sector: Healthcare
• Industry: Biotechnology

About: CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Employees: 15